Your Partner. For science. For life.
Battling chronic ailments. Evolving science. Improving quality of life. Even helping people get a better night’s sleep. Our portfolio companies are positively impacting the world every day with their visionary people and life-changing products.
What they do.
Verrica is developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and Molluscum contagiosum. Treatments currently approved by the FDA for these and similar conditions have only limited efficacy, are painful or require daily compliance for an extended treatment period to see results.
PBM partnered with an entrepreneurial Stanford PhD who had researched and discovered the opportunity. PBM is providing the capital and operational assistance in developing the programs. Verrica has partnered with some of the leading MDs in the world looking to develop a convenient, effective and safe product to outperform currently available treatment options.
Achievement of Note:
Verrica has developed and produced a proprietary drug product, developed a unique applicator, and is currently in clinical trials.
How they’re improving the quality of peoples’ lives:
Annually, millions of children get Molluscum contagiosum (caused by Pox Virus), which presents typically in 20+ rounded, dome-shaped, pink, waxy lesions all over the body. The virus is very contagious and there is no approved therapy. Verrica hopes to help these children by developing a pain-free, effective therapy to resolve the lesions.